Artificial Intelligence‐Empowered Single‐Cell Phenotyping for Rapid, Automated Pathogen Diagnostics
Advanced Science · 2026-11 · 13 (62)
DOI: 10.1002/advs.77334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.08.2026. Verfasst von Sabita Khadka und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Electrical, Computer, and Biomedical Engineering, Southern Illinois University, Carbondale, Illinois, USA. Hauptthemen laut MEDLINE: Single-Cell Analysis, Escherichia coli, Artificial Intelligence. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Southern Illinois University, SIU System Collaborative Grant Award.
Abstract (Originalsprache)
Accurate bacterial identification and antimicrobial susceptibility testing (AST) are essential for timely clinical decision‐making. Conventional diagnostic methods typically require 24–48 h, leading to inappropriate empirical therapy, accelerating antimicrobial resistance, and worsening patient outcomes. Here, we present an integrated diagnostic platform that combines microfluidic single‐cell bacterial detection with artificial intelligence (AI)‐driven analysis for rapid phenotypic AST. The microfluidic device enables stable time‐lapse detection of individual bacterial cells under designated, controlled antibiotic exposure, with a U‐Net–based AI model that automatically segments and quantifies the drug response of individual bacterial cells using phase‐contrast microscopy images. The trained model identified 96% of individual Escherichia coli ( E. coli ) cells and showed no false‐positive predictions on bacteria‐free images. Applied to AST, the integrated system quantified dose‐dependent growth inhibition of E. coli exposed to ciprofloxacin and trimethoprim/sulfamethoxazole, yielding resistance profiles, along with minimum inhibitory concentrations (MICs), within 2 h. These results are consistent with standard broth microdilution, demonstrating the potential of integrating microfluidics and AI for rapid, automated, and single‐cell–resolved pathogen diagnosis. Beyond rapid AST, the integrated microfluidic‐AI platform was further evaluated for automated identification of targeted infections, including E. coli and Staphylococcus aureus ( S. aureus ) in the presence of blood matrices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Electrical, Computer, and Biomedical Engineering, Southern Illinois University, Carbondale, Illinois, USA.
ORCID-Profile: Hui Li
Förderung
- Southern Illinois University
- SIU System Collaborative Grant Award
Zitieren
APA
Khadka, S., Raahat, B., Tragoudas, S., & Li, H. (2026). Artificial Intelligence‐Empowered Single‐Cell Phenotyping for Rapid, Automated Pathogen Diagnostics. Advanced Science, 13(62). https://doi.org/10.1002/advs.77334
Vancouver
Khadka S, Raahat B, Tragoudas S, Li H. Artificial Intelligence‐Empowered Single‐Cell Phenotyping for Rapid, Automated Pathogen Diagnostics. Advanced Science. 2026;13(62). doi:10.1002/advs.77334
BibTeX
@article{Khadka2026,
author = {Khadka, Sabita and Raahat, Bushra and Tragoudas, Spyros and Li, Hui},
title = {Artificial Intelligence‐Empowered Single‐Cell Phenotyping for Rapid, Automated Pathogen Diagnostics},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {62},
doi = {10.1002/advs.77334}
}
EUVIMED